Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is known as a highly aggressive malignant disease. Prognosis for patients is notoriously poor, despite improvements in surgical techniques and new (neo)adjuvant chemotherapy regimens. Early detection of PDAC may increase the overall survival. It is furthermore...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna-Sawires, Randa G., Schiphuis, Jorinde H., Wuhrer, Manfred, Vasen, Hans F. A., van Leerdam, Monique E., Bonsing, Bert A., Mesker, Wilma E., van der Burgt, Yuri E. M., Tollenaar, Rob A. E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961509/
https://www.ncbi.nlm.nih.gov/pubmed/33800786
http://dx.doi.org/10.3390/ijms22052655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961509/
https://www.ncbi.nlm.nih.gov/pubmed/33800786
http://dx.doi.org/10.3390/ijms22052655

Ejemplares similares